开盘$51.79
昨收$51.78
当日区间$50.76 – $54.64
成交量1.62M
市值$2.79B
市盈率（TTM）85.3
股息率–
VCEL 相关新闻
匹配 Vericel 或代码 VCEL 的头条新闻，按最新排序。
- TD Cowen Maintains Vericel(VCEL.US) With Buy Rating, Maintains Target Price $58
- Truist Financial Maintains Vericel(VCEL.US) With Buy Rating
- TD Cowen Maintains Vericel(VCEL.US) With Buy Rating, Raises Target Price to $58 正面
- Truist Financial Maintains Vericel(VCEL.US) With Buy Rating, Raises Target Price to $58 正面
- H.C. Wainwright Maintains Vericel(VCEL.US) With Buy Rating, Raises Target Price to $72 正面
- TD Cowen Maintains Vericel(VCEL.US) With Buy Rating, Maintains Target Price $55
- Analysts' Opinions Are Mixed on These Healthcare Stocks: Vericel (VCEL), Sarepta Therapeutics (SRPT) and Neumora Therapeutics, Inc. (NMRA)
- H.C. Wainwright Maintains Vericel(VCEL.US) With Buy Rating, Maintains Target Price $70
- Truist Financial Maintains Vericel(VCEL.US) With Buy Rating, Announces Target Price $54
- CCORF Maintains Vericel(VCEL.US) With Buy Rating, Maintains Target Price $58
- H.C. Wainwright Maintains Vericel(VCEL.US) With Buy Rating, Raises Target Price to $70 正面
- BTIG Maintains Vericel(VCEL.US) With Hold Rating
- Truist Financial Maintains Vericel(VCEL.US) With Buy Rating, Cuts Target Price to $42 负面
- H.C. Wainwright Maintains Vericel(VCEL.US) With Buy Rating, Raises Target Price to $64 正面
- Ladenburg Thalmann & Co. Sticks to Their Buy Rating for Vericel (VCEL)
暂无评论——快来第一个聊聊 VCEL。